Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04595994
Title Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications

osteosarcoma

sarcoma

leiomyosarcoma

alveolar soft part sarcoma

Therapies

Selinexor

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.